GRTX

GRTX Stock: From $6.61 To Over $8.80 Pre-Market Explanation

Galera Announces Updated Data from its Randomized, Multicenter, Placebo-Controlled Trial in Patients with Pancreatic Cancer

Galera Therapeutics to Present at the Oppenheimer 31st Annual Healthcare Conference

Galera Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

Galera Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Updates

Galera Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference

Galera Therapeutics Announces Interim Data from Pilot Phase 1/2 Trial of GC4419 in Combination with Stereotactic Body Radiation Therapy Showed Improved Overall Survival in Patients with Locally Advanced Pancreatic Cancer